Skip to main content

Personalised mobile health coaching from early pregnancy to 12-months postpartum for females at risk of gestational diabetes (Bump2Baby and Me): a multicentre, randomised controlled trial

In brief

Pregnancy-to-postpartum app coaching did not lower BMI at 12 months

In a trial of 865 pregnant people at increased risk of gestational diabetes, personalized smartphone coaching from pregnancy through 12 months postpartum produced virtually no difference in mean BMI change versus usual care. The intervention appeared safe, but it did not improve weight outcomes; future programs may need to target a broader range of maternal health measures.

Journal
The Lancet. Digital health (Q1)
Published
12 November 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Sharleen L O'Reilly, Fionnuala McAuliffe, Helena Teede, Christy Burden, Cristina Campoy, Helle T Maindal, et al.
PMID
43020746
DOI
10.1016/j.landig.2026.101059

Why clinicians should know about it

  • Picked for Health Informatics (top studies of the week, 15 November 2026): Multicentre trial evaluates personalised mobile health coaching

Abstract

BACKGROUND: Maternal overweight and obesity increase the risk of gestational diabetes and adverse pregnancy outcomes. Digital health interventions offer scalable, personalised support, but evidence for interventions spanning both pregnancy and postpartum remains scarce. We evaluated the effectiveness of a personalised mobile health (mHealth) coaching intervention for females at increased risk of gestational diabetes. METHODS: This multicentre, randomised controlled trial conducted in Australia, Ireland, Spain, and the UK enrolled pregnant females aged 18 years and older between 12-24 weeks of gestation with increased risk of gestational diabetes (Monash GDM risk tool score ≥3; tool risk factors were maternal age, BMI, ethnicity, family history of diabetes, and past history of gestational diabetes). Participants were randomly assigned (1:1) using computer-generated block randomisation (block size 200; stratified by site) to receive either personalised mHealth coaching via smartphone providing synchronous and asynchronous support through pregnancy to 12 months postpartum alongside usual maternity care, or usual maternity care alone. Usual maternity care, including gestational diabetes screening and management, continued unchanged in both groups, and both groups received Bluetooth-enabled scales. Participants and health coaches could not be masked to allocation; clinical staff providing usual care, laboratory staff, and trial statisticians were masked. The primary outcome was the between-group mean difference in BMI at 12 months postpartum among females at risk of gestational diabetes. The trial was registered at Australia and New Zealand Clinical Trials Register, ACTRN12620001240932. FINDINGS: Between Feb 9, 2021, and Oct 22, 2023, 4386 females were screened, 3521 were excluded, and 865 were randomly assigned (437 to the mHealth intervention group and 428 to the control group). The mean age of participants was 35·2 years (SD 4·3), and most participants were White (588 [73%] of 804). Mean BMI change did not differ between groups (intervention, -0·04 kg/m2 [SE 0·12] vs control, 0·04 kg/m2 [0·13]). Adverse events were recorded in 18% (79 of 437) of participants in the intervention group and 25% (106 of 428) of participants in the control group; serious adverse events occurred in 6% (28 of 437) of participants in the intervention group and 9% (40 of 428) of participants in the control group. No adverse or serious adverse events were considered related to the intervention. INTERPRETATION: Personalised mHealth coaching spanning pregnancy and an extended postpartum support period did not reduce mean maternal BMI at 12 months compared with usual care. Findings suggest that mHealth interventions targeting at-risk females might benefit from addressing a broader range of maternal health outcomes beyond weight management. FUNDING: European Union Commission Horizon 2020 and National Health and Medical Research Council of Australia.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.